Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
- Successful initial treatment of pectus excavatum patient in Australia - Data published in the European Journal of Plastic Surgery confirms Bellaseno’s novel approach in soft tissue engineering ...
-
- Company adds significant immunotherapy development expertise to its management team- Clinical trial of lead compound IOS-1002 to start in 2022 Schlieren (Zurich Area), Switzerland. – December...
-
- Promising data presented at Society for Immunotherapy of Cancer 36th Annual Meeting (SITC) - Multi-functional agent targeting three innate immune checkpoint receptors - Potential as monotherapy and...
-
- Strengthened management team headed by Jörg Neermann as CEO Goettingen, Germany, October 20, 2021 - Curexsys GmbH, a leader in the emerging field of therapeutic exosomes, today announced the...
-
- Preclinical data highlighting mode-of-action of lead program iosH2 Schlieren (Zurich Area), Switzerland. – October 13, 2021 – ImmunOs Therapeutics AG, a Swiss biotechnology company developing...
-
- Company prepares for further growth and entry into clinical development- Prof. Andrew Scott, Dmitriy Zamarin, MD, PhD, Prof. Dr. med. Dirk Jäger, and Jeffrey M. Bockman, PhD, appointed as clinical...
-
Dr. Weiss verfügt über mehr als 15 Jahre Erfahrung mit der Entwicklung von Biomarkern und In-vitro-Diagnostika Unternehmen hat gezielte Rekrutierungskampagne für die nächste Phase der...
-
Dr. Weiss brings more than 15 years of experience in biomarker and in vitro diagnostics development Company launched targeted recruiting campaign for next phase of corporate life cycle Cologne,...
-
- Seventure Partners and Novartis Pharmaceuticals join as new investors- Transformative treatment for millions of children with myopia Berlin, Germany, July 14, 2021 --- Dopavision, a company...
-
Company raises EUR 4 million to reach key value-creating milestones over the next 12-18 monthsKlaus Albrecht, Alluti GmbH, appointed as new member of the Supervisory Board Cologne, Germany, July...